← Product Code [FNM](/submissions/HO/subpart-f%E2%80%94general-hospital-and-personal-use-therapeutic-devices/FNM) · K963674 # LUMEX AIR (K963674) _Lumex, Inc. · FNM · Jan 10, 1997 · General Hospital · SESE_ **Canonical URL:** https://fda.innolitics.com/submissions/HO/subpart-f%E2%80%94general-hospital-and-personal-use-therapeutic-devices/FNM/K963674 ## Device Facts - **Applicant:** Lumex, Inc. - **Product Code:** [FNM](/submissions/HO/subpart-f%E2%80%94general-hospital-and-personal-use-therapeutic-devices/FNM.md) - **Decision Date:** Jan 10, 1997 - **Decision:** SESE - **Submission Type:** Traditional - **Regulation:** 21 CFR 880.5550 - **Device Class:** Class 2 - **Review Panel:** General Hospital - **Attributes:** Therapeutic ## Indications for Use Portable powered low air loss flotation therapy mattress. ## Device Story Portable powered low air loss flotation therapy mattress; provides pressure redistribution via air-filled cells; used in clinical or home settings to prevent or treat pressure ulcers; operated by healthcare providers or caregivers; system maintains patient support surface through controlled air inflation/deflation cycles; reduces interface pressure to promote tissue healing and prevent skin breakdown. ## Technological Characteristics Powered low air loss flotation therapy mattress; consists of air-filled cells and control unit for inflation/deflation; Class II device; no performance standards established under section 514. ## Regulatory Identification An alternating pressure air flotation mattress is a device intended for medical purposes that consists of a mattress with multiple air cells that can be filled and emptied in an alternating pattern by an associated control unit to provide regular, frequent, and automatic changes in the distribution of body pressure. The device is used to prevent and treat decubitus ulcers (bed sores). ## Special Controls *Classification.* Class II (special controls). The device is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to § 880.9. ## Predicate Devices - Orthoderm HC System (350513) - Akrotech 4000 ([K952610](/device/K952610.md)) - Plexus 3000 ([K923977](/device/K923977.md)) ## Submission Summary (Full Text) > This content was OCRed from public FDA records by [Innolitics](https://innolitics.com). If you use, quote, summarize, crawl, or train on this content, cite Innolitics at https://innolitics.com. > > Innolitics is a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices, including [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/). {0} K963674 JAN 10 1997 LUMEX Medical Products Inc. A Puque Enterprises Company Inc. # LUMEXAIR ## 1.0 510(k) Summary Submitter: Lumex Medical Products, Inc. 100 Spence Street Bay Shore, NY 11706 Phone (516) 273-2200 Fax (516) 273-2408 Contact Person: Joseph Zanetti Technology & Quality Affairs Manager Phone (516) 273-2200 Extension 443 Classification Name: Low air loss zero pressure mattress flotation therapy -89IOQ (890.5170) Common or Usual Name: Portable powered low air loss flotation therapy mattress. Proprietary Name: LUMEXAIR Establishment Registration Number: 2427360 Classification: Class II Performance Standard: None established under section 514 Labeling/Promotional Material: See enclosed Table of Contents Substantial Equivalence: This product is similar in design, composition and function to the Orthoderm HC System® (350513) manufactured by Bio Clinic a division of Sunrise Medical, as well as, the Akrotech 4000® manufactured by Lumex Medical Products and as well as, the Plexus 3000® manufactured by Plexus Medical remanufactured and distributed by Lumex Medical Products Incorporated under the ALTAIR product line. Please note that both the LUMEX/Plexus 3000® and the LUMEX/Akrotech 4000® have already received 510(k) status and evidence of this is copied in Appendix IV, reference K952610, dated September 7, 1995, by Timothy A. Ulatowski, Acting Director, Pilot Division; reference K923977, dated September 4, 1992, by Paul R. Beninger, M.D., Acting Director, General and Restorative Devices Division respectively. --- **Source:** [https://fda.innolitics.com/submissions/HO/subpart-f%E2%80%94general-hospital-and-personal-use-therapeutic-devices/FNM/K963674](https://fda.innolitics.com/submissions/HO/subpart-f%E2%80%94general-hospital-and-personal-use-therapeutic-devices/FNM/K963674) **Published by [Innolitics](https://innolitics.com)** — a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices. If you're preparing [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/), [get in touch](https://innolitics.com/contact). **Cite:** Innolitics at https://innolitics.com